OpenFilings

Immix Biopharma, Inc.

Form10-K/A

Report Period2025-12-31

Date Filed2026-03-27

Time Filed17:28:57

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K/A
EX-23.1
EX-23.1
EX-31.2
EX-32.1
Filing on SEC Edgar